
Just after midnight on the morning of Aug. 7, President Trump’s sweeping “reciprocal” tariffs took effect on dozens of international trading partners, marking another dramatic escalation of the administration’s “America First” trading policy.
On Aug. 2, AMCP submitted comments in response to the 21st Century Cures 2.0 Request for Information. AMCP’s comments detail the association’s support for many of the provisions included in the Cures 2.0 Act of 2021. The bill, introduced in the previous Congress by Congresswoman Diana DeGette (D-CO), would increase coverage of innovative technologies, improve Medicaid access to high-cost therapies, and improve post-marketing studies of drugs approved through accelerated pathways.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.